Lymphangiogenesis in development and disease

Novartis Foundation Symposium

Volumn 283, Issue , 2007, Pages 87-98

  Mäkinen, Taija ^a,c   Alitalo, Kari ^b  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BLOOD VESSEL; CELL DIFFERENTIATION; CYTOLOGY; ENDOTHELIUM CELL; GENERAL ASPECTS OF DISEASE; LYMPH VESSEL; LYMPHANGIOGENESIS; MOUSE; PRENATAL DEVELOPMENT;

ANIMALS; BLOOD VESSELS; CELL DIFFERENTIATION; DISEASE; ENDOTHELIAL CELLS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MICE;

EID: 40949158837     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (66)

1. Abtahian F, Guerriero A, Sebzda E et al 2003 Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 299:247-251
2. Achen MG, Jeltsch M, Kukk E et al 1998 Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548-553
3. Achen MG, McColl BK, Stacker SA 2005 Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7:121-127
4. Angeli V, Ginhoux F, Llodra J et al 2006 B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24:203-215
5. Baldwin ME, Halford MM, Roufail S et al 2005 Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol 25:2441-2449
6. Baluk P, Tammela T, Ator E et al 2005 Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115:247-257
7. Buttler K, Kreysing A, von Kaisenberg CS et al 2006 Mesenchymal cells with leukocyte and lymphendothelial characteristics in murine embryos. Dev Dyn 235:1554-1562
8. Byzova TV, Goldman CK, Jankau J et al 2002 Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood 99:4434-4442
9. Cao Y, Linden P, Farnebo J et al 1998 Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 95:14389-14394
10. Cao R, Bjorndahl MA, Religa P et al 2004 PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6:333-345
11. Chang LK, Garcia-Cardena G, Farnebo F et al 2004 Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci USA 101:11658-11663
12. Cursiefen C, Chen L, Borges LP et al 2004 VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113:1040-1050
13. Dixelius J, Makinen T, Wirzenius M et al 2003 Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J Biol Chem 278:40973-40979
14. Fang J, Dagenais SL, Erickson RP et al 2000 Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 67:1382-1388
15. Ferrell RE, Levinson KL, Esman JH et al 1998 Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum Mol Genet 7:2073-2078
16. Finegold DN, Kimak MA, Lawrence EC et al 2001 Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet 10:1185-1189
17. Foo SS, Turner CJ, Adams S et al 2006 Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124:161-173
18. Gale NW, Thurston G, Hackett SF et al 2002 Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3:411-23
19. He Y, Kozaki K, Karpanen T et al 2002 Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94:819-825
20. Hirakawa S, Kodama S, Kunstfeld R et al 2005 VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201:1089-1099
21. Hong YK, Foreman K, Shin JW et al 2004a Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36:683-685
22. Hong YK, Lange-Asschenfeldt B, Velasco P et al 2004b VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J 18:1111-1113
23. Iljin K, Petrova TV, Veikkola T et al 2002 A fluorescent Tie1 reporter allows monitoring of vascular development and endothelial cell isolation from transgenic mouse embryos. FASEB J 16:1764-1774
24. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M 2000 Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67:295-301
25. Irrthum A, Devriendt K, Chitayat D et al 2003 Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet 72:1470-1478
26. Jeltsch M, Kaipainen A, Joukov V et al 1997 Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425
27. Joukov V, Sorsa T, Kumar V et al 1997 Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16:3898-3911
28. Kajiya K, Hirakawa S, Ma B, Drinnenberg I, Detmar M 2005 Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 24:2885-2895
29. Karkkainen MJ, Ferrell RE, Lawrence EC et al 2000 Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25:153-159
30. Karkkainen MJ, Saaristo A, Jussila L et al 2001 A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 98:12677-12682
31. Karkkainen MJ, Haiko P, Sainio K et al 2004 Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5:74-80
32. Karpanen T, Makinen T 2006 Regulation of lymphangiogenesis-from cell fate determination to vessel remodeling. Exp Cell Res 312:575-583
33. Karpanen T, Egeblad M, Karkkainen MJ et al 2001 Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61:1786-1790
34. Karpanen T, Wirzenius M, Makinen T et al 2006 Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol 169:708-18
35. Kerjaschki D, Regele HM, Moosberger I et al 2004 Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15:603-612
36. Kriederman BM, Myloyde TL, Witte MH et al 2003 FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Hum Mol Genet 12:1179-1185
37. Kubo H, Cao R, Brakenhielm E et al 2002 Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci USA 99:8868-8873
38. Maisonpierre PC, Suri C, Jones PF et al 1997 Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
39. Makinen T, Jussila L, Veikkola T et al 2001a Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7:199-205
40. Makinen T, Veikkola T, Mustjoki S et al 2001b Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20:4762-4773
41. Makinen T, Adams RH, Bailey J et al 2005 PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 19:397-410
42. Mandriota SJ, Jussila L, Jeltsch M et al 2001 Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672-682
43. Maruyama K, Ii M, Cursiefen C et al 2005 Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115:2363-2372
44. Morisada T, Oike Y, Yamada Y et al 2005 Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 105:4649-4656
45. Nagy JA, Vasile E, Feng D et al 2002 Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196:1497-1506
46. Ny A, Koch M, Schneider M et al 2005 A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat Med 11:998-1004
47. Papoutsi M, Tomarev SI, Eichmann A et al 2001 Endogenous origin of the lymphatics in the avian chorioallantoic membrane. Dev Dyn 222:238-251
48. Pennisi D, Gardner J, Chambers D et al 2000 Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice. Nat Genet 24:434-437
49. Petrova TV, Makinen T, Makela TP et al 2002 Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21:4593-4599
50. Petrova TV, Karpanen T, Norrmen C et al 2004 Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 10:974-981
51. Pytowski B, Goldman J, Persaud K et al 2005 Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97:14-21
52. Saaristo A, Veikkola T, Tammela T et al 2002 Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med 196:719-730
53. Saaristo A, Tammela T, Timonen J et al 2004 Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. FASEB J 18:1707-1709
54. Saharinen P, Kerkela K, Ekman N et al 2005 Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J Cell Biol 169:239-243
55. Schoppmann SF, Birner P, Stockl J et al 2002 Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161:947-956
56. Shimizu K, Kubo H, Yamaguchi K et al 2004 Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci 95:328-333
57. Skobe M, Hawighorst T, Jackson DG et al 2001 Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-198
58. Stacker SA, Caesar C, Baldwin ME et al 2001 VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186-191
59. Szuba A, Skobe M, Karkkainen MJ et al 2002 Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J 16:1985-1957
60. Tammela T, Saaristo A, Lohela M et al 2005 Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 105:4642-4648
61. Veikkola T, Jussila L, Makinen T et al 2001 Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20:1223-1231
62. Wigle JT, Oliver G 1999 Prox1 function is required for the development of the murine lymphatic system. Cell 98:769-778
63. Wigle JT, Harvey N, Detmar M et al 2002 An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21:1505-1513
64. Wilting J, Papoutsi M, Schneider M, Christ B 2000 The lymphatic endothelium of the avian wing is of somitic origin. Dev Dyn 217:271-278
65. Yaniv K, Isogai S, Castranova D et al 2006 Live imaging of lymphatic development in the zebrafish. Nat Med 12:711-716
66. Zhang X, Groopman JE, Wang JF 2005 Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. J Cell Physiol 202:205-214